Thomas Lecompte

10.0k total citations · 2 hit papers
239 papers, 6.6k citations indexed

About

Thomas Lecompte is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, Thomas Lecompte has authored 239 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Hematology, 67 papers in Surgery and 66 papers in Internal Medicine. Recurrent topics in Thomas Lecompte's work include Venous Thromboembolism Diagnosis and Management (66 papers), Platelet Disorders and Treatments (55 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (52 papers). Thomas Lecompte is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (66 papers), Platelet Disorders and Treatments (55 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (52 papers). Thomas Lecompte collaborates with scholars based in France, Switzerland and Belgium. Thomas Lecompte's co-authors include Véronique Regnault, H.C. Hemker, Suzette Beguı́n, Peter Giesen, Rob Wagenvoord, Raed Al Dieri, Denis Wahl, Philippe Maincent, Emmanuel de Maistre and Nathalie Ubrich and has published in prestigious journals such as Nature, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Thomas Lecompte

221 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Calibrated Automated Thrombin Generation Measurement in Clotting Plasma

2003 1.1k citations Véronique Regnault, Thomas Lecompte et al. profile →
The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulability

2002 517 citations Véronique Regnault, Thomas Lecompte et al. profile →

Peers

Countries citing papers authored by Thomas Lecompte

Since Specialization

Citations

This map shows the geographic impact of Thomas Lecompte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Lecompte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Lecompte more than expected).

Fields of papers citing papers by Thomas Lecompte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Lecompte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Lecompte. The network helps show where Thomas Lecompte may publish in the future.

Co-authorship network of co-authors of Thomas Lecompte

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Lecompte. A scholar is included among the top collaborators of Thomas Lecompte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Lecompte. Thomas Lecompte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Guidance-Based Appropriateness of Hemostasis Testing in the Acute Setting 2025 ·Hämostaseologie ·(unknown), Deepa J. Arachchillage, Michaël Hardy, Alexandre Mansour, Émilie Catry, Mélanie Closset, Isabelle Gouin‐Thibault, (unknown), Thomas Lecompte, Lorenzo Alberio, Janne Cadamuro, Giuseppe Lippi, François Mullier	2
2	Results of an international survey on the management of therapeutic intensity unfractionated heparin: communication from the SSCs of the ISTH 2025 ·Journal of Thrombosis and Haemostasis ·Isabelle Gouin‐Thibault, (unknown), Jean M. Connors, Michaël Hardy, Alexandre Mansour, Virginie Siguret, Corinne Frère, Jerrold H. Levy, Adam Cuker, Thomas Lecompte, François Mullier	0
3	Thrombin Generation Assay in Antiphospholipid Antibodies Positive Subjects as a Personalized Thrombotic Risk Assessment: State of the Art and Perspectives 2024 ·Current Rheumatology Reports ·(unknown), Virginie Dufrost, Jérémy Lagrange, (unknown), Guillaume Mourey, Thomas Lecompte, N. Magy‐Bertrand, Véronique Regnault, Stéphane Zuily, Denis Wahl	2
4	Alpha‐2‐macroglobulin in hemostasis and thrombosis: An underestimated old double‐edged sword 2022 ·Journal of Thrombosis and Haemostasis ·Jérémy Lagrange, Thomas Lecompte, (unknown), Patrick Lacolley, Véronique Regnault	42
5	Impact of Fibrinogen Infusion on Thrombin Generation and Fibrin Clot Structure in Patients with Inherited Afibrinogenemia 2022 ·Thrombosis and Haemostasis ·Claudia Djambas Khayat, Rita Marchi, Stéphane Durual, Thomas Lecompte, Marguerite Neerman‐Arbez, Alessandro Casini	5
6	D-dimer Testing in Pulmonary Embolism with a Focus on Potential Pitfalls: A Narrative Review 2022 ·Diagnostics ·(unknown), Julien Favresse, Michaël Hardy, Jonathan Douxfils, Grégoire Le Gal, Pierre‐Marie Roy, Nick van Es, Cihan Ay, Hugo Ten Cate, Thierry Vander Borght, (unknown), Thomas Lecompte, Giuseppe Lippi, François Mullier	3
7	Functional Flow Cytometric Assay for Reliable and Convenient Heparin-Induced Thrombocytopenia Diagnosis in Daily Practice 2021 ·Biomedicines ·Brigitte Tardy, (unknown), Michèle Piot, Martine Alhenc‐Gelas, Philippe Nguyên, Ismaı̈l Elalamy, Andreas Greinacher, Emmanuel de Maistre, Dominique Lasne, Marie‐Hélène Horellou, Grégoire Le Gal, Thomas Lecompte, Bernard Tardy, (unknown)	7
8	Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review 2021 ·Journal of Clinical Medicine ·(unknown), Michaël Hardy, Jonathan Douxfils, Stéphanie Roullet, Dominique Lasne, Jerrold H. Levy, Alain Stépanian, Sophie Susen, Corinne Frère, Thomas Lecompte, François Mullier	42
9	Study of in vitro thrombin generation after neutralization of heparin 2021 ·International Journal of Laboratory Hematology ·Michaël Hardy, Jonathan Douxfils, Laure Morimont, (unknown), (unknown), Emmanuel de Maistre, Thomas Lecompte, François Mullier	9
10	Hypercoagulability (thrombin generation) in patients with cirrhosis is detected with ST‐Genesia 2020 ·Journal of Thrombosis and Haemostasis ·(unknown), Thomas Sinegre, Thomas Lecompte, Bruno Pereira, (unknown), Armand Abergel, Aurélien Lebreton	24
11	Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia 2020 ·Journal of Clinical Medicine ·Brigitte Tardy, Thomas Lecompte, François Mullier, Caroline Vayne, Claire Pouplard	39
12	Thromboprophylaxis and laboratory monitoring for in-hospital patients with Covid-19 - a Swiss consensus statement by the Working Party Hemostasis 2020 ·Swiss Medical Weekly ·Alessandro Casini, Lorenzo Alberio, Anne Angelillo‐Scherrer, Pierre Fontana, B. Gerber, Lukas Graf, Inga Hegemann, Wolfgang Korte, Johanna A. Kremer Hovinga, Thomas Lecompte, María Soledad Crúz Martínez, Michael Nagler, Jan–Dirk Studt, Dimitrios A. Tsakiris, Walter A. Wuillemin, Lars M. Asmis	69
13	Metagenomics analysis of the virome of 300 concentrates from a Swiss platelet bank 2018 ·Vox Sanguinis ·Francisco Brito, Samuel Cordey, Eric Delwart, Xutao Deng, Diderik Tirefort, (unknown), Evgeny M. Zdobnov, Thomas Lecompte, Laurent Kaiser, Sophie Waldvogel‐Abramowski, Olivier Preynat‐Seauve	7
14	Clinical characteristics and laboratory testing of patients with suspected HIT: A survey on current practice in 11 university hospitals in France 2010 ·Thrombosis Research ·Audrey Bidet, (unknown), Dominique Desprez, Emmanuel de Maistre, Émilie Presles, Thomas Lecompte, Cécile Lavenu‐Bombled, (unknown), Martine Wolf, Pierre‐Emmanuel Morange, E Racadot, C. Mouton, L. Grunebaum, Claire Pouplard, Bernard Tardy	6
15	Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopenia 2009 ·Thrombosis Research ·Ismaı̈l Elalamy, B. Tardy-Poncet, (unknown), Emmanuel de Maistre, Claire Pouplard, Philippe Nguyên, (unknown), Yves Gruel, Thomas Lecompte, Bernard Tardy, (unknown)	24
16	The effect of platelet activation on the hypercoagulability induced by murine monoclonal antiphospholipid antibodies 2008 ·Haematologica ·(unknown), Denis Wahl, Véronique Latger‐Cannard, Jean‐Pierre Max, Patrick Lacolley, Thomas Lecompte, Véronique Regnault	16
17	[Skin necrosis induced by heparin: apropos of 2 cases]. 2001 ·PubMed ·(unknown), Véronique Latger‐Cannard, Emmanuel de Maistre, (unknown), Elisabeth André, (unknown), S. Reichert, Thomas Lecompte	2
18	[Prophylaxis of venous thromboembolism in medical patients: from medical decision tools to the use of low molecular weight heparin]. 1999 ·PubMed ·Nathalie Thilly, (unknown), Charles D. Collard, Thomas Lecompte, (unknown)	4
19	[Pure genetic thrombocytopenia. A new clinical entity]. 1990 ·PubMed ·Y Najean, Thomas Lecompte	1
20	Tests d'agrégation plaquettaire dans 26 cas de thrombopénies induites par l'héparine (TIH). Problèmes méthodologiques, diagnostiques et aspects thérapeutiques. 1987 ·Journal des Maladies Vasculaires ·C Lecrubier, Thomas Lecompte, (unknown), MH Horellou, (unknown), M. Samama	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact